Drug information for PEGINTERFERON
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
180 Ug/0. 5mL
Prescription
PEGINTERFERON ALFA-2A
;
RIBAVIRIN
peginterferon alfa-2a
HOFFMAN-LA ROCHE
125083
2011-09-16 Review
2004-06-04 Letter
Drug Adverse Effects information for PEGINTERFERON
Role code
Indications
Reaction
# Reports
C
BLOOD PRESSURE
DEHYDRATION
2
C
BLOOD PRESSURE
HAEMATOCRIT DECREASED
2
C
BLOOD PRESSURE
HAEMOGLOBIN DECREASED
2
C
BLOOD PRESSURE
HAEMORRHOIDS
2
C
BLOOD PRESSURE
INSOMNIA
2
C
HEPATITIS C
ABDOMINAL DISCOMFORT
3
C
HEPATITIS C
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS
3
C
HEPATITIS C
ANAEMIA
12
C
HEPATITIS C
ANAL PRURITUS
3
C
HEPATITIS C
ANXIETY
6
C
HEPATITIS C
APLASTIC ANAEMIA
3
C
HEPATITIS C
ARTHRALGIA
6
C
HEPATITIS C
ASCITES
3
C
HEPATITIS C
ASTHENIA
6
C
HEPATITIS C
BACTERAEMIA
3
C
HEPATITIS C
BLOOD CREATININE INCREASED
3
C
HEPATITIS C
BLOOD POTASSIUM DECREASED
3
C
HEPATITIS C
BLOOD PRESSURE INCREASED
3
C
HEPATITIS C
BLOOD SODIUM DECREASED
3
C
HEPATITIS C
CELLULITIS
6
C
HEPATITIS C
CHEST PAIN
3
C
HEPATITIS C
COMPLETED SUICIDE
6
C
HEPATITIS C
CONFUSIONAL STATE
3
C
HEPATITIS C
CONSTIPATION
3
C
HEPATITIS C
CONVULSION
3
C
HEPATITIS C
DEHYDRATION
9
C
HEPATITIS C
DEPRESSION
6
C
HEPATITIS C
DIARRHOEA
6
C
HEPATITIS C
DISORIENTATION
6
C
HEPATITIS C
DIZZINESS
6
C
HEPATITIS C
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
15
C
HEPATITIS C
DYSPHAGIA
3
C
HEPATITIS C
DYSPNOEA
3
C
HEPATITIS C
FACIAL ASYMMETRY
3
C
HEPATITIS C
FEELING ABNORMAL
3
C
HEPATITIS C
FLUID OVERLOAD
3
C
HEPATITIS C
GASTROENTERITIS
3
C
HEPATITIS C
HAEMATOCRIT DECREASED
3
C
HEPATITIS C
HAEMOGLOBIN DECREASED
3
C
HEPATITIS C
HAEMORRHAGE INTRACRANIAL
3
C
HEPATITIS C
HAEMORRHOIDS
3
C
HEPATITIS C
HEADACHE
3
C
HEPATITIS C
HEART RATE INCREASED
6
C
HEPATITIS C
HEPATIC CIRRHOSIS
3
C
HEPATITIS C
HOSPITALISATION
3
C
HEPATITIS C
HYPOCALCAEMIA
3
C
HEPATITIS C
HYPONATRAEMIA
3
C
HEPATITIS C
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
3
C
HEPATITIS C
INCREASED TENDENCY TO BRUISE
3
C
HEPATITIS C
INSOMNIA
3
C
HEPATITIS C
LETHARGY
3
C
HEPATITIS C
LOSS OF CONSCIOUSNESS
3
C
HEPATITIS C
MALAISE
3
C
HEPATITIS C
MENTAL STATUS CHANGES
3
C
HEPATITIS C
MOOD SWINGS
3
C
HEPATITIS C
MYALGIA
6
C
HEPATITIS C
NAUSEA
12
C
HEPATITIS C
NEUTROPENIA
6
C
HEPATITIS C
OEDEMA PERIPHERAL
6
C
HEPATITIS C
OPTIC NEURITIS
3
C
HEPATITIS C
PANCREATIC ENZYMES INCREASED
3
C
HEPATITIS C
PANCYTOPENIA
3
C
HEPATITIS C
PNEUMONIA
6
C
HEPATITIS C
PNEUMONITIS
3
C
HEPATITIS C
POSTMENOPAUSAL HAEMORRHAGE
3
C
HEPATITIS C
PRURITUS
6
C
HEPATITIS C
RASH
9
C
HEPATITIS C
RASH GENERALISED
3
C
HEPATITIS C
RASH PAPULAR
3
C
HEPATITIS C
RASH PRURITIC
3
C
HEPATITIS C
RENAL FAILURE
9
C
HEPATITIS C
RETINAL EXUDATES
3
C
HEPATITIS C
RHABDOMYOLYSIS
3
C
HEPATITIS C
SEPSIS
6
C
HEPATITIS C
SWELLING FACE
6
C
HEPATITIS C
THROMBOCYTOPENIA
3
C
HEPATITIS C
TONGUE DISORDER
3
C
HEPATITIS C
TOXICITY TO VARIOUS AGENTS
3
C
HEPATITIS C
VIRAL INFECTION
3
C
HEPATITIS C
VOMITING
3
C
HEPATITIS C
WEIGHT DECREASED
3
C
PRODUCT USED FOR UNKNOWN INDICATION
ANAEMIA
1
C
PRODUCT USED FOR UNKNOWN INDICATION
ASTHENIA
1
C
PRODUCT USED FOR UNKNOWN INDICATION
CONFUSIONAL STATE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
DISORIENTATION
1
C
PRODUCT USED FOR UNKNOWN INDICATION
INCREASED TENDENCY TO BRUISE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
LETHARGY
1
C
PRODUCT USED FOR UNKNOWN INDICATION
POSTMENOPAUSAL HAEMORRHAGE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
WEIGHT DECREASED
1
C
RASH
DEHYDRATION
1
C
RASH
HAEMATOCRIT DECREASED
1
C
RASH
HAEMOGLOBIN DECREASED
1
C
RASH
HAEMORRHOIDS
1
C
RASH
INSOMNIA
1
Ads by Google